My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 713

    1.

    Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

    Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC.

    Breast Cancer Res. 2008;10(4):R67. Epub 2008 Aug 5.PMID: 18681955 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.

    Bryan BB, Schnitt SJ, Collins LC.

    Mod Pathol. 2006 May;19(5):617-21.PMID: 16528377 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.

    Steinman S, Wang J, Bourne P, Yang Q, Tang P.

    Ann Clin Lab Sci. 2007 Spring;37(2):127-34.PMID: 17522367 [PubMed - indexed for MEDLINE]Related articles

    4.

    Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

    Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC.

    JAMA. 2006 Jun 7;295(21):2492-502.PMID: 16757721 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.

    van der Groep P, van Diest PJ, Menko FH, Bart J, de Vries EG, van der Wall E.

    J Clin Pathol. 2009 Oct;62(10):926-30. Epub 2009 Jun 18.PMID: 19541683 [PubMed - indexed for MEDLINE]Related articles

    6.

    Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

    Marotti JD, Collins LC, Hu R, Tamimi RM.

    Mod Pathol. 2010 Feb;23(2):197-204. Epub 2009 Nov 6.PMID: 19898422 [PubMed - in process]Related articles

    7.

    Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

    Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.

    Hum Pathol. 2006 Sep;37(9):1217-26. Epub 2006 Jul 18.PMID: 16938528 [PubMed - indexed for MEDLINE]Related articles

    8.

    Identification of a basal-like subtype of breast ductal carcinoma in situ.

    Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC.

    Hum Pathol. 2007 Feb;38(2):197-204.PMID: 17234468 [PubMed - indexed for MEDLINE]Related articles

    9.

    Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.

    González LO, Corte MD, Junquera S, González-Fernández R, del Casar JM, García C, Andicoechea A, Vázquez J, Pérez-Fernández R, Vizoso FJ.

    Hum Pathol. 2009 Sep;40(9):1224-33. Epub 2009 May 12.PMID: 19439346 [PubMed - indexed for MEDLINE]Related articles

    10.

    p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.

    Megha T, Ferrari F, Benvenuto A, Bellan C, Lalinga AV, Lazzi S, Bartolommei S, Cevenini G, Leoncini L, Tosi P.

    J Clin Pathol. 2002 Jun;55(6):461-6.PMID: 12037031 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

    Paredes J, Lopes N, Milanezi F, Schmitt FC.

    Virchows Arch. 2007 Jan;450(1):73-80. Epub 2006 Nov 23.PMID: 17123107 [PubMed - indexed for MEDLINE]Related articles

    12.

    Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.

    Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B.

    Anticancer Res. 2005 May-Jun;25(3A):1719-23.PMID: 16033090 [PubMed - indexed for MEDLINE]Related articles

    13.

    Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

    Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM.

    Mod Pathol. 2006 Feb;19(2):264-71.PMID: 16341146 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.

    Kusińska R, Potemski P, Jesionek-Kupnicka D, Kordek R.

    Pol J Pathol. 2005;56(3):107-10.PMID: 16334976 [PubMed - indexed for MEDLINE]Related articles

    15.

    Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.

    Guler G, Huebner K, Himmetoglu C, Jimenez RE, Costinean S, Volinia S, Pilarski RT, Hayran M, Shapiro CL.

    Cancer. 2009 Feb 15;115(4):899-908.PMID: 19130459 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Expression of basal and luminal cytokeratins in breast cancer and their correlation with clinicopathological prognostic variables.

    Mohammadizadeh F, Naimi A, Rajabi P, Ghasemibasir H, Eftekhari A.

    Indian J Med Sci. 2009 Apr;63(4):152-62.PMID: 19414985 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.

    Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE.

    Am J Surg Pathol. 2009 Jul;33(7):1093-7.PMID: 19390427 [PubMed - indexed for MEDLINE]Related articles

    18.

    Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ.

    Tang P, Wang X, Schiffhauer L, Wang J, Bourne P, Yang Q, Quinn A, Hajdu S.

    Ann Clin Lab Sci. 2006 Spring;36(2):137-43.PMID: 16682508 [PubMed - indexed for MEDLINE]Related articles

    19.

    Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

    Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

    J Surg Res. 2007 Nov;143(1):109-18.PMID: 17950079 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

    Brower ST, Ahmed S, Tartter PI, Bleiweiss I, Amberson JB.

    Ann Surg Oncol. 1995 Sep;2(5):440-4.PMID: 7496840 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk